| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.64▲ | 2.66▲ | 2.66▲ | 2.56▲ | 2.58▲ |
| MA10 | 2.67▲ | 2.70▲ | 2.60▲ | 2.52▲ | 2.60▲ |
| MA20 | 2.75▼ | 2.57▲ | 2.55▲ | 2.60▲ | 2.93▼ |
| MA50 | 2.64▲ | 2.52▲ | 2.52▲ | 2.61▲ | 2.93▼ |
| MA100 | 2.56▲ | 2.53▲ | 2.59▲ | 2.96▼ | 3.92▼ |
| MA200 | 2.56▲ | 2.59▲ | 2.57▲ | 2.79▼ | 3.87▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.019▼ | 0.006▲ | 0.019▲ | 0.013▲ | -0.009▼ |
| RSI | 51.705▲ | 59.631▲ | 60.176▲ | 57.221▲ | 49.090▼ |
| STOCH | 31.806 | 30.900 | 38.362 | 42.047 | 29.488 |
| WILL %R | -48.276 | -57.576 | -57.576 | -45.455 | -51.402 |
| CCI | 13.538 | 24.062 | 64.276 | 223.386▲ | 20.076 |
| ▲ BREAK | $AVXL Price Breaks 10 Days High | Set Alert |
| ▲ GAP | $AVXL Open Gap Up %2 | Set Alert |
| ▲ GAP | $AVXL Open Gap Up %3 | Set Alert |
| ▲ GAP | $AVXL Open Gap Up %5 | Set Alert |
| MA | $AVXL Price Crossed Above MA(7) | Set Alert |
| MA | $AVXL Price Crossed Above MA(13) | Set Alert |
| MA | $AVXL Price Crossed Above MA(26) | Set Alert |
| MA | $AVXL Price Crossed Above MA(50) | Set Alert |
| ▲ MACD | $AVXL MACD(12,26,9) Crossed Above Signal Line | Set Alert |
| RSI | $AVXL RSI(14) Crossed Above 50 | Set Alert |
| ▲ RSI&VOL | $AVXL RSI Cross Up and Volume | Set Alert |
| ▲ RSI&MACD | $AVXL MACD cross and RSI above 55 | Set Alert |
| ▲ PSAR&MOM | $AVXL PSAR Switch Up + Momentum | Set Alert |
|
Friday, October 19, 2018 10:22 AM
Today, Maxim Group set its price target on Anavex Life Sciences Corp (NASDAQ:AVXL) to $7.00 per share. There are 4 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.
|
|
Friday, October 19, 2018 09:53 AM
Anavex Life Sciences Corp. (NASDAQ: AVXL) jumped 17 percent to $2.89 after reporting the FDA approval of Investigational New Drug Application for Phase 2 trial of ANAVEX 2-73 in patients with Rett syn...
|
|
Friday, October 19, 2018 09:02 AM
Anavex Life Sciences (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/10/18 | 2.96 | 3.10 | 2.52 | 2.75 | 2,490,100 |
| 18/10/18 | 2.46 | 2.50 | 2.41 | 2.47 | 122,086 |
| 17/10/18 | 2.46 | 2.54 | 2.44 | 2.46 | 173,813 |
| 16/10/18 | 2.59 | 2.62 | 2.50 | 2.52 | 106,667 |
| 15/10/18 | 2.39 | 2.65 | 2.39 | 2.58 | 148,108 |
| 12/10/18 | 2.51 | 2.54 | 2.44 | 2.47 | 87,539 |
| 11/10/18 | 2.41 | 2.50 | 2.3801 | 2.47 | 205,908 |
| 10/10/18 | 2.57 | 2.6001 | 2.45 | 2.45 | 145,877 |
| 09/10/18 | 2.49 | 2.69 | 2.49 | 2.59 | 324,442 |
| 08/10/18 | 2.38 | 2.62 | 2.38 | 2.48 | 190,817 |
|
|
||||
|
|
||||
|
|
||||
|
|